The CPH Group Packaging Division new film coating facility in Anápolis, Brazil, is expected to commence operations in the fourth quarter of this year. To ensure that the facility can be supplied with domestically produced mono PVC films, the Packaging Division has entered into an exclusive collaboration with Brazil-based mono PVC film manufacturer Cipatex.
As part of the new collaboration, CPH will support the modernization of a calendering facility at Cipatex’s São Paulo plant to align it fully to pharmaceutical mono PVC film requirements. The films produced will then be further processed at the Perlen Packaging Anápolis plant and coated with PVdC.
“The new Anápolis film coating facility will be our Packaging Division’s third, joining similar plants in Switzerland and China, in line with our overall strategy of maintaining our own coating capacities in the pharmaceuticals sector’s key centers in Europe, Asia, and the Americas,” says Peter Schildknecht, CEO of the CPH Group. “And our collaboration with Cipatex will ensure that our new Anápolis plant is assured of local supplies of high-quality mono PVC films.” This underlines the division’s strategy of ensuring the long-term, reliable supply of raw materials to the production sites.
“The demand for pharmaceutical packaging solutions has been growing steadily in the Latin American market—and in Brazil in particular—since we commenced our activities in South America over 20 years ago,” adds Marc Haller, head of the Packaging Division of the CPH Group. “With our investment in our Anápolis site and our new partnership with Cipatex, we can offer the full range of products— from mono films to coated blister pack films—from our local Brazilian production facilities.”
Perlen Packaging’s Anápolis site is located in Brazil’s rapidly growing second-biggest pharmaceutical industry cluster. Many of the country’s leading pharmaceutical customers are situated nearby. The latest market projections confirm the continuing growth trend in Latin America’s pharmaceuticals markets, which are expected to show annual growth of between 5% and 8% from now to 2026.
